Spontaneous regression of localized neuroblastoma detected by mass screening

Journal of Clinical Oncology

Volumn 16, Issue 4, 1998, Pages 1265-1269

  Yamamoto, Keiko ^a   Hanada, Ryoji ^b   Kikuchi, Akira ^b   Ichikawa, Masataka ^b   Aihara, Toshinori ^b   Oguma, Eiji ^b   Moritani, Toshio ^b   Shimanuki, Yoshihisa ^b   Tanimura, Masako ^b   Hayashi, Yasuhide ^b  

^a SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HOMOVANILLIC ACID; VANILMANDELIC ACID;

ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CANCER REGRESSION; CANCER SCREENING; CANCER STAGING; CHILD; CLINICAL ARTICLE; DNA CONTENT; FEMALE; GENE AMPLIFICATION; HUMAN; MALE; MASS SCREENING; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; TUMOR LOCALIZATION;

EID: 0031901652     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.4.1265     Document Type: Article

References (26)

1. Sawada T, Hirayama M, Nakata T, et al: Mass screening for neuroblastoma in infants in Japan. Lancet 2:271-272, 1984
2. Parker L, Craft AW, Dale G, et al: Screening for neuroblastoma in the north of England. Br Med J 305:1260-1263, 1992
3. Woods WG, Tuchman M, Robinson LL, et al: A population-based study of the usefulness of screening for neuroblastoma. Lancet 348:1682-1687, 1996
4. Yamamoto K, Hayashi Y, Hanada R, et al: Mass screening and age specific incidence of neuroblastoma in Saitama Prefecture, Japan. J Clin Oncol 13:2033-2038, 1995
5. Hayashi Y, Hanada R, Yamamoto K: Biology of neuroblastoma in Japan found by screening. Am J Pediatr Hematol Oncol 14:342-347, 1992
6. Kaneko Y, Kanda N, Maseki N, et al: Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastoma: A chromosome and N-myc amplification study. J Clin Oncol 8:2005-2013, 1990
7. Hayashi Y, Kanda N, Inaba T, et al: Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer 63:126-132, 1989
8. Brodeur GM, Hayes FA, Green AA, et al: Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients. Cancer Res 47:4248-4253, 1987
9. Matsumura M, Tsunoda A, Nishi T, et al: Spontaneous regression of neuroblastoma detected by mass screening. Lancet 338:447-448, 1990 (letter)
10. Iwata M, Koshinaga T, Okabe I, et al: Biological characteristics of neuroblastoma with spontaneous tumor reduction: A case report. J Pediatr Surg 30:722-723, 1995
11. Evans AE, D'Angio GJ, Randolph J: A proposed staging for children with neuroblastoma. Children's Cancer Study Group A. Cancer 27:374-378, 1971
12. Shimada H, Chatten J, Newton WA, et al: Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73:405-416, 1984
13. Asami T, Otabe N, Wakabayashi M, et al: Screening for neuroblastoma: A 9 year birth cohort-based study in Niigata, Japan. Acta Paediatr 84:1173-1176, 1995
14. Bessho F: Effect of mass screening on age-specific incidence of neuroblastoma. Int J Cancer 67:520-522, 1996
15. Hayashi Y, Inaba T, Hanada R, et al: Chromosome findings and prognosis in 15 patients with neuroblastoma found by VMA mass screening. J Pediatr 112:567-571, 1988
16. Look AT, Hayes FA, Shuster JJ, et al: Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood 15 neuroblastoma: A Pediatric Oncology Group study. J Clin Oncol 9:581-591, 1991
17. Nakagawara A, Nakagawara MA, Scavarda NJ, et al: Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 328:847-854, 1993
18. Brodeur GM: Molecular basis for heterogeneity in human neuroblastoma. Eur J Cancer 31A:4:505-510, 1995
19. Ambros PF, Ambros IM, Strehl S, et al: Regression and progression in neuroblastoma. Does genetics predict tumour behaviour? Eur J Cancer 31A:4:510-515, 1995
20. Everson TC: Spontaneous regression of cancer. Ann NY Acad Sci 114:721-735, 1964
21. Carlsen NLT: How frequent is spontaneous remission of neuroblastomas? Implications for screening. Br J Cancer 61:441-446, 1990
22. Matthay KK, Sather HN, Seeger RC, et al: Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. J Clin Oncol 7:236-244, 1989
23. Bernard BD, Conte M, Macini A, et al: Localized resectable neuroblastoma: Results of the second study of the Italian Cooperative Group for Neuroblastoma. J Clin Oncol 13:884-893, 1995
24. Kushner BH, Cheug NV, LaQuaglia MP, et al: Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy. J Clin Oncol 14:373-381, 1996
25. Kerbl R, Urban CE, Lackner H, et al: Connatal localized neuroblastoma. The case to delay treatment. Cancer 77:1395-1401, 1996
26. Ambros IM, Zellner A, Roald B, et al: Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma. N Engl J Med 334:1505-1511, 1996